Intracorneal Rings Market: Rise in prevalence of eye diseases such as myopia with retinal damage to drive the market

Intracorneal rings are also known as intracorneal ring segment or ICRS. These rings are made of biocompatible and clear plastic and can be safely used in cataract surgery and contact lenses.

Intracorneal rings are also known as intracorneal ring segment or ICRS. These rings are made of biocompatible and clear plastic and can be safely used in cataract surgery and contact lenses. These are micro thin inserts with different thicknesses. Additionally, these rings are used as alternatives in corneal transplant. Intracorneal rings are designed to reshape the surface of eye, improve the cone shape of and reinforce the cornea. These rings help to improve the shape of cornea and enhance vision in keratoconus patients. Moreover, intracorneal rings eliminate the need of corneal grafts and improve structural integrity of eye. These are mostly used in keratoconus, and low and moderate myopia. Keratoconus is an eye condition characterized by corneal irregularity and loss of vision. Intracorneal rings are used as alternatives in the treatment of keratoconus.

Read Report Overview - https://www.transparencymarketresearch.com/intracorneal-rings-market.html

Rise in prevalence of eye diseases such as myopia with retinal damage, cataract, and glaucoma is anticipated to drive the global intracorneal rings market. Additionally, increase in the number of corneal transplantation surgeries and high incidence of acute and moderate myopia are projected to propel the intracorneal rings market. Patients suffering from diabetes are at major risk of developing eye disease and could require eye surgery. Hence, increase in the diabetic population is expected to augment the global intracorneal rings market. However, lack of awareness about intracorneal rings is likely to restrain the intracorneal rings market.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=57969

The global intracorneal rings market can be segmented based on technique, indication, end-user, and region. In terms of technique, the intracorneal rings market can be bifurcated into mechanical and femtosecond laser. Growth of the mechanical segment can be attributed to rise in prevalence of cataract, glaucoma, and other eye diseases. Based on indication, the global intracorneal rings market can be classified into myopia, keratoconus, and pellucid marginal degeneration. Growth of the myopia segment can be attributed to factors such as increase in incidence of vision loss and corneal irregularity leading to vision impairment. In terms of end-user, the market can be divided into hospitals, eye clinics, and others.

Request for Analysis of COVID-19 Impact on Intracorneal Rings Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=57969

The global intracorneal rings market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The intracorneal rings market in North America is projected to be driven by rise in prevalence of glaucoma during the forecast period. According to the National Federation of Blind, 0.78% of the total population of the U.S. was suffering from visual disabilities in 2015. Rise in prevalence of cataract, glaucoma, and other eye-related infections are anticipated to propel the intracorneal rings market in Europe from 2018 to 2026. Moreover, increase in incidence of diabetes is expected to augment the intracorneal rings market in the region. According to the State of Nation Eye Health (U.K.) (2016), cataract accounts for 19% and glaucoma accounts for 7% of the cases of vision loss in U.K. According to the Royal National Institutes of Blind People, in 2014, prevalence of diabetes retinopathy was 56.1% in people suffering from type 1 diabetes and 30.0% in people with type 2 diabetes. An article published in Asia Pacific Journal of Ophthalmology stated that 80% to 90% of young people are suffering from myopia. Moreover, diabetes is one of the most prevalent lifestyle diseases in the region. According to the International Diabetes Federation, 72,946,400 people were diagnosed with diabetes in India in 2017.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=57969

The global intracorneal rings market is highly fragmented due to the presence of large number of players. Key players operating in the global intracorneal rings market are DIOPTEX, Johnson & Johnson Surgical Vision, Inc., AJL Ophthalmic SA, Spectrum Surgical Pty. Ltd., MEDIPHACOS, Carl Zeiss Meditec AG, Rockmed, Gamma Vision, and Ziemer Ophthalmic Systems AG, among others.

Pre Book Intracorneal Rings Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=57969&ltype=S

More Trending Reports by Transparency Market Research:

Depression Drugs Market Depression today has emerged as a ‘silent killer’ in several regions around the world, particularly in urban cities. The prevalence of depression continues to grow at a rapid pace and has considerably high mortality and morbidity rate due to which, the healthcare sector continues its pursuit for novel medications and therapies. At present, tricyclic antidepressants, selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), and atypical antidepressants among others.

Exosome Technologies Market The outbreak of severe acute respiratory syndrome β-coronavirus 2 (SARS-CoV-2) has led to a potential long-lasting global health crisis. Thus, extracellular vesicles (EVs) are emerging as a possible solution for improving lung immunity. Companies in the exosome technologies market are increasing their research for conducting the pathogenesis of various lung diseases and viral infections in order to keep economies running during the COVID-19 outbreak.

Gynecology Drugs Market Gynecological diseases represent a collective term given to different medical conditions specific to the female reproductive system. Thus, gynecological diseases include conditions affecting the uterus, ovaries and their appendages. Gynecology drugs are the therapeutics utilized for the treatment of various gynecological diseases and symptoms. The global gynecological devices market was valued at US$ 53,376.96 Mn in 2017. It is expected to expand at a CAGR of 5.5% from 2018 to 2026.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/